Enhanced Intraocular Physiological Sensors for Glaucoma Management
Legal Citation
Summary of the Inventive Concept
The inventive concept discloses a suite of improvements to intraocular physiological sensors, enabling continuous monitoring, personalized treatment, and enhanced safety features for glaucoma patients.
Background and Problem Solved
The original patent, 'Intraocular physiological sensor', provided a foundational approach to measuring intraocular pressure. However, it had limitations in terms of continuous monitoring, personalized treatment, and sensor maintenance. The new inventive concept addresses these limitations by introducing advanced features, such as multi-point pressure measurement, self-cleaning mechanisms, and real-time data transmission.
Detailed Description of the Inventive Concept
The inventive concept comprises multiple components: (1) an implantable intraocular sensor with a self-cleaning mechanism, ensuring accurate measurements over time; (2) a data processing unit that calculates pressure gradients across the eye; (3) a system for personalized glaucoma management, utilizing machine learning algorithms to analyze pressure data and provide tailored treatment recommendations; and (4) a real-time intraocular pressure monitoring system, alerting patients and healthcare providers of abnormal readings. These advancements enable more effective glaucoma diagnosis, monitoring, and treatment.
Novelty and Inventive Step
The new inventive concept introduces several novel features, including the self-cleaning mechanism, pressure gradient calculation, and personalized treatment recommendations. These innovations provide a significant improvement over the original patent, offering enhanced safety, accuracy, and personalized care for glaucoma patients.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include variations in sensor design, data processing algorithms, and notification systems. For example, the sensor could be miniaturized for easier implantation, or the data processing unit could utilize artificial intelligence to identify patterns indicative of glaucoma. Additionally, the notification system could be integrated with existing healthcare infrastructure to facilitate seamless communication between patients and healthcare providers.
Potential Commercial Applications and Market
The enhanced intraocular physiological sensors have significant commercial potential in the ophthalmology and healthcare industries. They could be marketed as a premium product for glaucoma patients, offering improved monitoring and treatment outcomes. The sensors could also be integrated into existing healthcare systems, providing a new revenue stream for healthcare providers and manufacturers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B3/16 |
| A | A61 | A61B3/0025 |
| A | A61 | A61B5/076 |
| A | A61 | A61B2560/0257 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically implantable physiological sensors for ophthalmological monitoring, involving biomedical engineering, microelectronics, and sensor design with expertise in intraocular pressure measurement technologies
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer with advanced degree, specialized knowledge in medical sensor design, familiarity with microfluidic systems, signal processing algorithms, and implantable medical device miniaturization techniques
Obviousness Rationale
A person having ordinary skill would recognize that the PTD's disclosed variations represent predictable incremental improvements to the source patent's intraocular pressure sensing system. The proposed enhancements like self-cleaning mechanisms, pressure gradient calculations, and machine learning analysis are logical extensions of existing sensor technologies. These modifications would be considered routine optimization strategies within the field of implantable medical sensors.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,262 |
|---|---|
| Title | Intraocular physiological sensor |
| Assignee(s) | Glaukos Corporation |